[Microscopic Hematuria : Reasonable and Risk-adapted Diagnostic Evaluation]

Overview

Journal Urologe A

Specialty Urology

Date 2017 Jun 24

PMID 28643107

Authors

N Lobig

F Wezel

T Martini

B Schroppel

C Bolenz

Affiliations

Soon will be listed here.

Abstract

Background: Microscopic hematuria that is not explained by an obvious underlying condition is a frequent and often an incidental finding that commonly triggers urological or nephrological evaluation. Potential underlying conditions range from benign to severe malignant diseases of the kidneys and urinary tract.

Materials And Methods: A nonsystematic literature search was performed, focusing on potential urological and nephrological causes of hematuria. National and international guidelines were considered and diagnostic as well as follow-up strategies are discussed. We provide a recommendation for practices in the clinical evaluation of hematuria.

Results: The overall prevalence for microscopic hematuria is estimated at approximately 2%, whereas risk populations show an increase to around 30%. In 13-35% of patients presenting with microscopic hematuria, a medical or surgical intervention is required. Malignant tumors of the kidneys or urinary tract can be diagnosed in 2.6-4% of all patients and in up to 25.8% of at-risk populations. "Idiopathic microscopic hematuria" without an obvious underlying medical condition accounts for approximately 80% of patients with asymptomatic hematuria. After exclusion of nephrological diseases, standard diagnostic procedures by means of medical history, physical and laboratory examination as well as ultrasound of the kidneys and the urinary tract should be performed. In the presence of risk factors, an extended diagnostic work-up using cystoscopy, urinary cytology, and cross-sectional imaging of the upper urinary tract is indicated.

Conclusion: Evidence-based strategies of a risk-adapted diagnostic evaluation for microscopic hematuria are not available. The development of reliable clinical and molecular markers offers great potential for the identification of patients at higher risk for harboring severe diseases.

References

Messing E, YOUNG T, Hunt V, Emoto S, Wehbie J . The significance of asymptomatic microhematuria in men 50 or more years old: findings of a home screening study using urinary dipsticks. J Urol. 1987; 137(5):919-22. DOI: 10.1016/s0022-5347(17)44294-7. View

Sears C, Ward J, Sears S, Puckett M, Kane C, Amling C . Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J Urol. 2002; 168(6):2457-60. DOI: 10.1016/S0022-5347(05)64167-5. View

Topham P, Jethwa A, Watkins M, Rees Y, Feehally J . The value of urine screening in a young adult population. Fam Pract. 2004; 21(1):18-21. DOI: 10.1093/fampra/cmh105. View

Millan-Rodriguez F, Salvador-Bayarri J, Vicente-Rodriguez J . Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups. J Urol. 2000; 164(4):1183-7. View

Silverman S, Leyendecker J, Amis Jr E . What is the current role of CT urography and MR urography in the evaluation of the urinary tract?. Radiology. 2009; 250(2):309-23. DOI: 10.1148/radiol.2502080534. View

Takahashi N, Glockner J, Hartman R, King B, Leibovich B, Stanley D . Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. J Urol. 2010; 183(4):1330-65. DOI: 10.1016/j.juro.2009.12.031. View

Yamagata K, Takahashi H, Tomida C, Yamagata Y, Koyama A . Prognosis of asymptomatic hematuria and/or proteinuria in men. High prevalence of IgA nephropathy among proteinuric patients found in mass screening. Nephron. 2002; 91(1):34-42. DOI: 10.1159/000057602. View

Jaffe J, Ginsberg P, Gill R, Harkaway R . A new diagnostic algorithm for the evaluation of microscopic hematuria. Urology. 2001; 57(5):889-94. DOI: 10.1016/s0090-4295(00)01124-9. View

Davis R, Stephen Jones J, Barocas D, Castle E, Lang E, Leveillee R . Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012; 188(6 Suppl):2473-81. DOI: 10.1016/j.juro.2012.09.078. View

10.

Thompson I . The evaluation of microscopic hematuria: a population-based study. J Urol. 1987; 138(5):1189-90. DOI: 10.1016/s0022-5347(17)43545-2. View

11.

Steiner H, Bergmeister M, Verdorfer I, Granig T, Mikuz G, Bartsch G . Early results of bladder-cancer screening in a high-risk population of heavy smokers. BJU Int. 2008; 102(3):291-6. DOI: 10.1111/j.1464-410X.2008.07596.x. View

12.

Messing E, YOUNG T, Hunt V, Newton M, Bram L, Vaillancourt A . Hematuria home screening: repeat testing results. J Urol. 1995; 154(1):57-61. DOI: 10.1016/s0022-5347(01)67224-0. View

13.

Jones D, Langstaff R, Holt S, Morgans B . The value of cystourethroscopy in the investigation of microscopic haematuria in adult males under 40 years. A prospective study of 100 patients. Br J Urol. 1988; 62(6):541-5. DOI: 10.1111/j.1464-410x.1988.tb04422.x. View

14.

Suzuki Y, Sasagawa I, Abe Y, Suzuki H, Kubota Y, Nakada T . Indication of cystoscopy in patients with asymptomatic microscopic haematuria. Scand J Urol Nephrol. 2000; 34(1):51-4. DOI: 10.1080/003655900750016896. View

15.

Davides K, King L, Jacobs D . Management of microscopic hematuria: twenty-year experience with 150 cases in a community hospital. Urology. 1986; 28(6):453-5. DOI: 10.1016/0090-4295(86)90142-1. View

16.

Edwards T, Dickinson A, Gosling J, McInerney P, Natale S, McGrath J . Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up. BJU Int. 2010; 107(2):247-52. DOI: 10.1111/j.1464-410X.2010.09521.x. View

17.

Howard R, Golin A . Long-term followup of asymptomatic microhematuria. J Urol. 1991; 145(2):335-6. DOI: 10.1016/s0022-5347(17)38331-3. View

18.

Bolenz C, West A, Ortiz N, Kabbani W, Lotan Y . Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?. Urol Oncol. 2011; 31(3):366-71. DOI: 10.1016/j.urolonc.2011.01.017. View

19.

Carson 3rd C, Segura J, Greene L . Clinical importance of microhematuria. JAMA. 1979; 241(2):149-50. View

20.

Dikranian A, Petitti D, Shapiro C, Kosco A . Intravenous urography in evaluation of asymptomatic microscopic hematuria. J Endourol. 2005; 19(5):595-7. DOI: 10.1089/end.2005.19.595. View